Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

New research paves the way for non-hormonal endometriosis treatments

Roughly 200 million women around the world suffer from endometriosis, a condition that causes tissue from the lining of the uterus to grow in places outside of the uterus.

22 Mar 2025

Duke-NUS and NUS Medicine launch first-ever joint center to drive metabolomics research

In a strategic move for medical research and innovation, Duke-NUS Medical School and the National University of Singapore Yong Loo Lin School of Medicine (NUS Medicine) have launched the Systems Metabolomics Centre (SysMeC), their first-ever joint research center.

22 Mar 2025

Exploring the therapeutic potential of flavonoids in type 2 diabetes

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder with a rapidly increasing global prevalence. It is primarily characterized by insulin resistance, β-cell dysfunction, and impaired glucose homeostasis.

20 Mar 2025

Smartwatch data could offer new way to assess cardiovascular health

The answer to your heart health may be on your wrist, a new study suggests. Researchers have developed a new way to assess cardiovascular health based on information routinely collected by smartwatches, according to a study being presented at the American College of Cardiology's Annual Scientific Session (ACC.25).

20 Mar 2025

Cell map offers insights into endometrial dysfunction in women with PCOS

Women with polycystic ovary syndrome (PCOS) find it harder to get pregnant, have more frequent miscarriages and have a higher risk of developing endometrial cancer.

20 Mar 2025

Healthcare professionals need better support to recognize T1DE

Healthcare professionals need better support to help recognize and treat symptoms of disordered eating in people living with type 1 Diabetes, according to new research from the University of Surrey.

20 Mar 2025

Clinical trial investigates osteoporosis medication for type 1 diabetes

City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States and a top research center for diabetes and other life-threatening illnesses, is leading a phase 1/2 clinical trial investigating an osteoporosis medication as a way to improve beta cell health in people with early type 1 diabetes.

19 Mar 2025

Early use of anti-obesity medication doubles weight loss

Adding an anti-obesity medication just one month after behavioral therapy begins-rather than waiting the currently recommended six months-can more than double weight loss for patients who struggle initially with lifestyle changes alone, according to new research published in Nature Medicine from a team at the Perelman School of Medicine at the University of Pennsylvania.

18 Mar 2025

Biomanufacturing platform offers a sustainable alternative to synthesizing peptide-based pharmaceuticals

To tackle the inequity in medication access, a societal issue especially in developing nations, a team of undergraduate student-researchers at the University of Ottawa has developed a new biomanufacturing platform called Phytogene.

18 Mar 2025

Keto controversy? Experts say it’s here to stay

Low-carb and ketogenic diets offer sustainable solutions for chronic disease, enhancing metabolic health and supporting weight loss through dietary changes.

18 Mar 2025

Could a little spice in your diet prevent gestational diabetes?

Eating chili once a month during pregnancy is linked to a significantly lower risk of gestational diabetes, while dried beans and bean soup showed no clear association.

17 Mar 2025

Study links inflammation pathways to changes in bone mineral density

In one of the first studies of its kind, a team of researchers from Keck School of Medicine of USC has found that proteins and pathways involved in inflammation are associated with changes in bone mineral density (BMD) over time.

14 Mar 2025

National survey reveals high public interest in medically tailored food programs

Researchers have conducted the first national survey on public awareness and perceptions of food, health, and Food is Medicine programs.

14 Mar 2025

Social advantage reduces risk of age-related diseases and slows aging

People with favorable socioeconomic conditions, such as high incomes or education levels, face a reduced risk of age-related diseases and show fewer signs of biological aging than peers of the same age, finds a new study led by University College London (UCL) researchers.

14 Mar 2025

New insights into screening and treatment for diabetic retinal disease

Diabetes affects more than 1 in 10 adults worldwide and has been accompanied by an increase in vision-threatening diabetic retinal disease.

12 Mar 2025

Apple peels beat some diabetes drugs at blocking blood sugar spikes

Researchers found that apple peels from local and commercial varieties are rich in phenolic compounds with antioxidant and antidiabetic properties. The local cultivar Amarilla de Octubre showed the highest bioactivity, suggesting potential for nutraceutical and pharmaceutical applications.

12 Mar 2025

Waist-to-height ratio more accurate than BMI for detecting childhood obesity

Body mass index (BMI) was almost three times more likely to classify children as overweight than waist circumference-to-height ratio, according to a new study.

12 Mar 2025

Limiting TV time may reduce heart disease risk for people with genetic risk for diabetes

Watching no more than one hour of TV a day may lower the risk of heart attack, stroke and other blood vessel diseases among people with varying levels of genetic risk for Type 2 diabetes, including high genetic risk, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

12 Mar 2025

Tirzepatide helps people without diabetes lose 13% body weight in real-world study

A real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at least six months lost an average of 12.9% of their body weight. The study highlights Tirzepatide’s potential as an effective off-label obesity treatment before its formal FDA approval for weight loss.

11 Mar 2025

Workplace culture as a key factor in lifestyle medicine adoption

Workplace culture plays an integral role in the successful adoption of lifestyle medicine programming within health systems, according to a new study published in BMJ Open.

11 Mar 2025

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

New research paves the way for non-hormonal endometriosis treatments

Duke-NUS and NUS Medicine launch first-ever joint center to drive metabolomics research

Exploring the therapeutic potential of flavonoids in type 2 diabetes

Smartwatch data could offer new way to assess cardiovascular health

Cell map offers insights into endometrial dysfunction in women with PCOS

Healthcare professionals need better support to recognize T1DE

Clinical trial investigates osteoporosis medication for type 1 diabetes

Early use of anti-obesity medication doubles weight loss

Biomanufacturing platform offers a sustainable alternative to synthesizing peptide-based pharmaceuticals

Keto controversy? Experts say it’s here to stay

Could a little spice in your diet prevent gestational diabetes?

Study links inflammation pathways to changes in bone mineral density

National survey reveals high public interest in medically tailored food programs

Social advantage reduces risk of age-related diseases and slows aging

New insights into screening and treatment for diabetic retinal disease

Apple peels beat some diabetes drugs at blocking blood sugar spikes

Waist-to-height ratio more accurate than BMI for detecting childhood obesity

Limiting TV time may reduce heart disease risk for people with genetic risk for diabetes

Tirzepatide helps people without diabetes lose 13% body weight in real-world study

Workplace culture as a key factor in lifestyle medicine adoption

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in